Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy
Objective: To investigate the effects of estrogen replacement therapy (ERT) on laryngeal cytology in postmenopausal women. Design: Prospective open clinical trial. Setting: Outpatient menopausal clinic in the Department of Gynecology, University of Catania, Catania, Italy. Patient(s): Eighty-four he...
Saved in:
Published in | Fertility and sterility Vol. 74; no. 6; pp. 1073 - 1079 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.12.2000
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective: To investigate the effects of estrogen replacement therapy (ERT) on laryngeal cytology in postmenopausal women.
Design: Prospective open clinical trial.
Setting: Outpatient menopausal clinic in the Department of Gynecology, University of Catania, Catania, Italy.
Patient(s): Eighty-four healthy, surgically postmenopausal women, of whom 48 were treated with ERT and 36 were considered as a control group.
Intervention(s): Transdermal E
2 treatment by patches or gel, evaluation of laryngeal cytology with cytobrush by indirect laryngoscopy, and questionnaire for the voice history.
Main Outcome Measure(s): Changes in cytologic aspects of laryngeal cells with respect to vaginal cytology by hematoxylin and eosin staining; subjective voice changes.
Result(s): Sixty-seven women completed the study. Ten women from the ERT group and five from the control group dropped out because of the invasive laryngoscope method; two subjects in the control group were excluded because of pathologies of the vocal cord. Hematoxylin and eosin staining confirmed similar superficial-intermediate aspects of the cells between the laryngeal and the vaginal smears in ERT-treated women. In the control group, both smears showed aspects of atrophy-dystrophy. The ERT group had a subjectively better quality of voice than the control group.
Conclusion(s): Our study confirms that the larynx is an estrogen target, as are vaginal cells. ERT may provide prevention and treatment of dystrophic pathologies of the vocal cords in postmenopausal women. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0015-0282 1556-5653 |
DOI: | 10.1016/S0015-0282(00)01582-X |